99 related articles for article (PubMed ID: 15738713)
21. Long duration stabilization of porous silicon membranes in physiological media: Application for implantable reactors.
Baraket A; Alcaraz JP; Gondran C; Costa G; Nonglaton G; Gaillard F; Cinquin P; Cosnier ML; Martin DK
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110359. PubMed ID: 31923938
[TBL] [Abstract][Full Text] [Related]
22. Transport characterization of membranes for immunoisolation.
Dionne KE; Cain BM; Li RH; Bell WJ; Doherty EJ; Rein DH; Lysaght MJ; Gentile FT
Biomaterials; 1996 Feb; 17(3):257-66. PubMed ID: 8745322
[TBL] [Abstract][Full Text] [Related]
23. Nanoporous alumina capsules for cellular macroencapsulation: transport and biocompatibility.
La Flamme KE; Mor G; Gong D; La Tempa T; Fusaro VA; Grimes CA; Desai TA
Diabetes Technol Ther; 2005 Oct; 7(5):684-94. PubMed ID: 16241869
[TBL] [Abstract][Full Text] [Related]
24. Long-term viability of transplanted hybrid cellular spheroids within chondrocyte sheets.
Lee JI; Kim JY; Kim HW; Bae SJ; Joo DJ; Huh KH; Fang YH; Jeong JH; Kim MS; Kim YS
Transplant Proc; 2012 May; 44(4):1162-5. PubMed ID: 22564653
[TBL] [Abstract][Full Text] [Related]
25. Diffusion properties of an artificial membrane used for Langerhans islets encapsulation: interest of an in vitro test.
Kessler L; Pinget M; Aprahamian M; Poinsot D; Keipes M; Damgé C
Transplant Proc; 1992 Jun; 24(3):953-4. PubMed ID: 1604681
[No Abstract] [Full Text] [Related]
26. On-line competitive immunoassay based on capillary electrophoresis applied to monitoring insulin secretion from single islets of Langerhans.
Tao L; Aspinwall CA; Kennedy RT
Electrophoresis; 1998 Mar; 19(3):403-8. PubMed ID: 9551792
[TBL] [Abstract][Full Text] [Related]
27. Nonporous polyurethane membranes as islet immunoisolation matrices--biocompatibility studies.
George S; Nair PD; Risbud MV; Bhonde RR
J Biomater Appl; 2002 Apr; 16(4):327-40. PubMed ID: 12099511
[TBL] [Abstract][Full Text] [Related]
28. Diffusion into human islets is limited to molecules below 10 kDa.
Williams SJ; Schwasinger-Schmidt T; Zamierowski D; Stehno-Bittel L
Tissue Cell; 2012 Oct; 44(5):332-41. PubMed ID: 22717091
[TBL] [Abstract][Full Text] [Related]
29. In vitro function of islets of Langerhans encapsulated with a membrane of porcine chondrocytes for immunoisolation.
Pollok JM; Lorenzen M; Kölln PA; Török E ; Kaufmann PM; Kluth D; Bohuslavizki KH; Gundlach M; Rogiers X
Dig Surg; 2001; 18(3):204-10. PubMed ID: 11464010
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo studies of the properties of an artificial membrane for pancreatic islet encapsulation.
Kessler L; Pinget M; Aprahamian M; Dejardin P; Damgé C
Horm Metab Res; 1991 Jul; 23(7):312-7. PubMed ID: 1774016
[TBL] [Abstract][Full Text] [Related]
31. Insulin secretion profiles are modified by overexpression of glutamate dehydrogenase in pancreatic islets.
Carobbio S; Ishihara H; Fernandez-Pascual S; Bartley C; Martin-Del-Rio R; Maechler P
Diabetologia; 2004 Feb; 47(2):266-76. PubMed ID: 14689183
[TBL] [Abstract][Full Text] [Related]
32. Structure-function relationships in pancreatic islets: support for intraislet modulation of insulin secretion.
Hopcroft DW; Mason DR; Scott RS
Endocrinology; 1985 Nov; 117(5):2073-80. PubMed ID: 2864239
[TBL] [Abstract][Full Text] [Related]
33. Size-selective diffusion in nanoporous but flexible membranes for glucose sensors.
Uehara H; Kakiage M; Sekiya M; Sakuma D; Yamonobe T; Takano N; Barraud A; Meurville E; Ryser P
ACS Nano; 2009 Apr; 3(4):924-32. PubMed ID: 19323485
[TBL] [Abstract][Full Text] [Related]
34. Methods for controlling the pore properties of ultra-thin nanocrystalline silicon membranes.
Fang DZ; Striemer CC; Gaborski TR; McGrath JL; Fauchet PM
J Phys Condens Matter; 2010 Nov; 22(45):454134. PubMed ID: 21339620
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic islets and insulinoma cells express a novel isoform of group VIA phospholipase A2 (iPLA2 beta) that participates in glucose-stimulated insulin secretion and is not produced by alternate splicing of the iPLA2 beta transcript.
Ramanadham S; Song H; Hsu FF; Zhang S; Crankshaw M; Grant GA; Newgard CB; Bao S; Ma Z; Turk J
Biochemistry; 2003 Dec; 42(47):13929-40. PubMed ID: 14636061
[TBL] [Abstract][Full Text] [Related]
36. Experimental evaluation and computational modeling of the effects of encapsulation on the time-profile of glucose-stimulated insulin release of pancreatic islets.
Buchwald P; Cechin SR; Weaver JD; Stabler CL
Biomed Eng Online; 2015 Mar; 14():28. PubMed ID: 25889474
[TBL] [Abstract][Full Text] [Related]
37. Insulin secretion in aging: studies with sequential gating of secretion vesicle margination and lysis.
Goodman M; Leitner JW; Sussman KE; Draznin B
Endocrinology; 1986 Aug; 119(2):827-32. PubMed ID: 2426091
[TBL] [Abstract][Full Text] [Related]
38. Control of complement activities for immunoisolation.
Iwata H; Murakami Y; Ikada Y
Ann N Y Acad Sci; 1999 Jun; 875():7-23. PubMed ID: 10415554
[TBL] [Abstract][Full Text] [Related]
39. Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations.
Leoni L; Desai TA
IEEE Trans Biomed Eng; 2001 Nov; 48(11):1335-41. PubMed ID: 11686632
[TBL] [Abstract][Full Text] [Related]
40. Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose.
Ritzel RA; Hansen JB; Veldhuis JD; Butler PC
J Clin Endocrinol Metab; 2004 Feb; 89(2):795-805. PubMed ID: 14764798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
